A detailed history of Yarbrough Capital, LLC transactions in Incyte Corp stock. As of the latest transaction made, Yarbrough Capital, LLC holds 4,990 shares of INCY stock, worth $373,252. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,990
Previous 4,990 -0.0%
Holding current value
$373,252
Previous $302,000 8.94%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

BUY
$70.23 - $86.01 $350,447 - $429,189
4,990 New
4,990 $360,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Yarbrough Capital, LLC Portfolio

Follow Yarbrough Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yarbrough Capital, LLC with notifications on news.